Inventor · disambiguated record
Pek Yoke Chong
Also filed as: CHONG PEK Y · CHONG PEK YOKE
7 granted patents·4 pending applications·44 citations·filing 2003–2024
82Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD4CHONG PEK YOKE2AQUINO CHRISTOPHER JOSEPH1GLAXO GROUP LTD1GLAXOSMITHKLINE INTELLECTUAL1
Top patents by PatentIndex Score
11 records- 0188US10358427B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 23, 2019·11 cites·8 claims
- 0281US8304419B2Chemical compoundsCHONG PEK YOKE·Filed 2008·Granted Nov 6, 2012·11 cites·17 claims
- 0376US7645771B2CCR5 antagonists as therapeutic agentsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jan 12, 2010·16 cites·4 claims
- 0475US8927593B2Benzofuran compounds for the treatment of hepatitis C virus infectionsCHONG PEK YOKE·Filed 2012·Granted Jan 6, 2015·4 cites·3 claims
- 0575US2025066361A15,6,7,7a-Tetrahydrocyclopenta[f]pyrido[1,2-h][1,7] naphthyridin-11(4bH)-one Compounds and Methods of use Use (as amended)GLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0672US9682999B2Benzofuran compounds for the treatment of hepatitis C virus infectionsGLAXO GROUP LTD·Filed 2014·Granted Jun 20, 2017·2 cites·12 claims
- 0765US12221444B25,6,7,7a-tetrahydrocyclopenta[f]pyrido[1,2-h][1,7]naphthyridin-11(4bH)-one compounds and methods of useGLAXOSMITHKLINE INTELLECTUAL·Filed 2021·Granted Feb 11, 2025·0 cites·9 claims
- 0853US2020255428A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 0952US2009053172A1Heterocyclic compounds as ccr5 antagonistsAQUINO CHRISTOPHER JOSEPH·Filed 2008·Application pending·0 cites
- 1043US10472336B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Nov 12, 2019·0 cites·11 claims
- 1141US2020291008A1Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pek Yoke Chong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →